Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Operating Leases: 2022-2023

Historic Operating Leases for Cullinan Therapeutics (CGEM) over the last 2 years, with Sep 2023 value amounting to $2.4 million.

  • Cullinan Therapeutics' Operating Leases fell 38.73% to $2.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $2.4 million, marking a year-over-year decrease of 38.73%. This contributed to the annual value of $3.6 million for FY2022, which is N/A change from last year.
  • Per Cullinan Therapeutics' latest filing, its Operating Leases stood at $2.4 million for Q3 2023, which was down 10.53% from $2.7 million recorded in Q2 2023.
  • In the past 5 years, Cullinan Therapeutics' Operating Leases registered a high of $4.0 million during Q3 2022, and its lowest value of $596,000 during Q2 2022.
  • Moreover, its 2-year median value for Operating Leases was $2.7 million (2023), whereas its average is $2.5 million.
  • Over the last 5 years, Cullinan Therapeutics' Operating Leases had its largest YoY gain of 358.72% in 2023, and its largest YoY loss of 38.73% in 2023.
  • Over the past 2 years, Cullinan Therapeutics' Operating Leases (Quarterly) stood at $3.6 million in 2022, then crashed by 38.73% to $2.4 million in 2023.
  • Its last three reported values are $2.4 million in Q3 2023, $2.7 million for Q2 2023, and $3.2 million during Q1 2023.